Current Investment
Kashi Clinical Laboratories
Prairie Capital Fund VII
| Location | Portland, Oregon |
| Transaction Type | Growth Buyout with Founder and Management |
| Investment Date | June 2024 |
| Business | Fully accredited clinical laboratory providing specialized solutions to academic institutions, biopharma, hospitals and transplant centers. |
| Industry | Healthcare |
Investment Rationale
- Partnership with reputable founder and experienced management team
- Diverse customer base in large, growing and fragmented end markets
- Technical, niche services with high barriers to entry
- Acclaimed for customer service, turnaround time, scientific expertise and innovation
- Expansive service offering provides a one-stop solution for academic institutions, biopharma and hospitals
Value Add
- Human Capital
- Sales & Marketing
- Technology
- Infrastructure
- Add-on Acquisitions
TEAM:
For the past few years, I have recognized the abundant growth opportunities within Kashi Clinical Laboratories (KCL). Therefore, I decided to partner with a like-minded entity that shares our values and vision to act as a catalyst in realizing these opportunities. I believe that aligning with Prairie represents a pivotal investment in KCL’s future success. I look forward to the fresh perspectives and operational enhancements that Prairie will bring, leveraging their expertise and networks to drive positive change.